Ruxolitinib video reaction

June 17th 2025

Food Insecurity and the Dangers of Infant Formula Dilution

The federal agency has assigned a target action date of January 31, 2026, for a decision.

January 30th 2023

FDA will not meet original PDUFA date for sebetralstat to treat HAE

FDA will not meet original PDUFA data for sebetralstat to treat HAE | Image Credit: Contemporary Pediatrics

Demystifying Infant Formula

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks.

October 11th 2022

Father’s teen diet linked to children’s healthy eating habits

Morgan Ebert, Managing Editor

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children.

June 13th 2025

FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Related Content

June 17th 2025

Food Insecurity and the Dangers of Infant Formula Dilution

The federal agency has assigned a target action date of January 31, 2026, for a decision.

January 30th 2023

FDA will not meet original PDUFA date for sebetralstat to treat HAE

Demystifying Infant Formula

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks.

October 11th 2022

Father’s teen diet linked to children’s healthy eating habits

Morgan Ebert, Managing Editor

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children.

June 13th 2025